Using this schedule, we treated mice bearing HCT116 TP53–/– tumour xenografts (Fig. 4e) with individual inhibitors or their combination for 8 days, then followed them for a further 5 days, when tumours in the control group reached predetermined size limits. The gene discussed is TP53; the disease is neoplasm.